PTGS2 and type 1 diabetes mellitus: Similarly, metformin prevents astrocyte activation and reduces inflammatory markers (Trem1, Dap12, Il1b and Tnfa) and oxidative stress markers (MDA, NO, iNOS and COX-2) in various brain regions in T1D models [184–186].